Alan Landay to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Alan Landay has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.075
-
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment. Clin Infect Dis. 2007 Mar 01; 44(5):749-54.
Score: 0.075